Peer-reviewedCC BY-NC-NDTranslational andrology and urology22 Oct 2026

Oxybutynin for hot flashes in men on androgen-deprivation therapy: interpreting the Alliance A222001 trial.

Adam Greenstein¹
Mauricio Vassallo¹
Navid Jabalameli¹
Soroush Rais-Bahrami^1,2,3,4

4 affiliations

¹Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
²Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
³Department of Cancer Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
⁴Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Read full text PDF DOI Cite

Comparative outcomes of radical prostatectomy, radiotherapy, and radiotherapy plus androgen deprivation therapy for high-risk and very high-risk prostate cancer: a narrative review
Translational andrology and urology15 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
An Immunocompetent Mouse Model of Degarelix Induced Chemical Castration to Investigate Acquired Resistance to Androgen Deprivation.
A. Robotham, D. Costanzo-Garvey, G. Waldron +2
bioRxiv7 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
Effects of androgen deprivation therapy on cerebral glucose metabolism in prostate cancer.
Song Xue, Honghu Zhang, Yifan Jiang +6
EJNMMI research1 Jul 2026Peer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCDOAJ
Fracture and Vertebral Augmentation Utilization Following Androgen Deprivation Therapy in Men With Prostate Cancer: A Propensity Score–matched Cohort Study
Taha Taka, Carson Cummings, Sarah Meng +7
Global Spine Journal13 Oct 2026Peer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
Trial-reported arthralgia of androgen deprivation therapy plus androgen receptor signaling inhibitors in prostate cancer: evidence from phase III randomized trials
Zhenping Han, Jing Tian, Zhuangcheng Huang +6
BMC Cancer30 Jul 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC

Cite

BibTeX RIS

BibTeX

@article{greenstein2026oxybutynin,
  title = {{Oxybutynin for hot flashes in men on androgen-deprivation therapy: interpreting the Alliance A222001 trial.}},
  author = {Adam Greenstein and Mauricio Vassallo and Navid Jabalameli and Soroush Rais-Bahrami},
  journal = {Translational andrology and urology},
  year = {2026},
  month = oct,
  doi = {10.21037/tau-2026-0764},
  url = {https://europepmc.org/article/MED/42997252},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Oxybutynin for hot flashes in men on androgen-deprivation therapy: interpreting the Alliance A222001 trial.
AU  - Adam Greenstein
AU  - Mauricio Vassallo
AU  - Navid Jabalameli
AU  - Soroush Rais-Bahrami
PY  - 2026
DA  - 2026/10/22
JO  - Translational andrology and urology
DO  - 10.21037/tau-2026-0764
UR  - https://europepmc.org/article/MED/42997252
SN  - 2223-4691
ER  -

Related

Cite